Healio/OSN top five from Twitter
Recent items have discussed a new Iluvien trial and the history of Bausch + Lomb. Check out five popular items from Healio/OSN’s best-performing tweets below:
Alimera enrolls first patient in Iluvien trial
Alimera Sciences has initiated enrollment for its prospective Iluvien study New Day. Read more.
BLOG: Bausch + Lomb
It feels like it happened just last fall. I can hardly believe that it’s been 17 years since Bausch + Lomb turned 150 years old, but the numbers don’t lie. Read more.
Autologous limbal stem cell transplantation successful in patients with chemical burn
Cultivated autologous limbal stem cell transplantation was successfully performed at Massachusetts Eye and Ear in four patients with chemical burns. Read more.
Ophthalmologists who make ergonomic adjustments may reduce risk of back pain
Ophthalmologists are at a high risk of musculoskeletal disorders of the back, shoulders, neck and arms, according to a speaker at the virtual Women in Ophthalmology Summer Symposium. Read more.
When to use which MIGS approach is a nuanced decision
New devices, advancements in technology and unique MIGS approaches provide an expansive landscape for surgeons to manage IOP without invasive incisional surgeries or increasing medication burdens. Read more.